Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin
Source: thedailycitizen.com